Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Sell
12,133
-1,202
-9% -$141K 0.04% 158
2026
Q1
$1.62M Buy
13,335
+665
+5% +$76.8K 0.05% 123
2025
Q4
$1.33M Sell
12,670
-253
-2% -$23.7K 0.04% 133
2025
Q3
$1.08M Sell
12,923
-1,321
-9% -$109K 0.03% 151
2025
Q2
$1.13M Sell
14,244
-13,510
-49% -$1.07M 0.04% 142
2025
Q1
$2.49M Buy
27,754
+5
+0% +$467 0.1% 88
2024
Q4
$2.76M Buy
27,749
+5,951
+27% +$614K 0.11% 66
2024
Q3
$2.48M Sell
21,798
-134
-0.6% -$15.9K 0.1% 74
2024
Q2
$2.72M Buy
21,932
+1,226
+6% +$158K 0.12% 63
2024
Q1
$2.73M Buy
20,706
+115
+0.6% +$14.2K 0.12% 65
2023
Q4
$2.24M Buy
20,591
+72
+0.4% +$7.47K 0.11% 71
2023
Q3
$2.11M Buy
20,519
+273
+1% +$29.4K 0.11% 70
2023
Q2
$2.34M Buy
20,246
+102
+0.5% +$11.6K 0.13% 59
2023
Q1
$2.14M Buy
20,144
+61
+0.3% +$6.59K 0.12% 67
2022
Q4
$2.23M Sell
20,083
-666
-3% -$68.1K 0.13% 61
2022
Q3
$1.79M Sell
20,749
-480
-2% -$42.9K 0.12% 64
2022
Q2
$1.94M Sell
21,229
-97
-0.5% -$8.6K 0.12% 65
2022
Q1
$1.75M Buy
21,326
+8,272
+63% +$652K 0.11% 70
2021
Q4
$1M Buy
13,054
+209
+2% +$16.6K 0.06% 100
2021
Q3
$965K Buy
12,845
+165
+1% +$12.5K 0.07% 97
2021
Q2
$986K Sell
12,680
-788
-6% -$58.6K 0.08% 89
2021
Q1
$991K Sell
13,468
-688
-5% -$50.8K 0.22% 79
2020
Q4
$1.1M Buy
14,156
+1,032
+8% +$78.9K 0.27% 65
2020
Q3
$1.04M Sell
13,124
-573
-4% -$44.9K 0.32% 58
2020
Q2
$1.01M Buy
13,697
+355
+3% +$26.7K 0.3% 59
2020
Q1
$980K Buy
13,342
+222
+2% +$17.4K 0.38% 53
2019
Q4
$1.14M Buy
13,120
+881
+7% +$72.4K 0.35% 56
2019
Q3
$983K Sell
12,239
-17
-0.1% -$1.36K 0.38% 51
2019
Q2
$981K Sell
12,256
-7,360
-38% -$564K 0.39% 50
2019
Q1
$1.56M Buy
19,616
+980
+5% +$73.3K 0.59% 41
2018
Q4
$1.36M Sell
18,636
-332
-2% -$23.4K 0.62% 42
2018
Q3
$1.28M Sell
18,968
-1,919
-9% -$122K 0.51% 46
2018
Q2
$1.21M Sell
20,887
-733
-3% -$41.4K 0.48% 46
2018
Q1
$1.12M Sell
21,620
-556
-3% -$30K 0.36% 49
2017
Q4
$1.19M Sell
22,176
-710
-3% -$39.4K 0.39% 49
2017
Q3
$1.4M Sell
22,886
-2,093
-8% -$127K 0.41% 40
2017
Q2
$1.53M Sell
24,979
-793
-3% -$48.3K 0.45% 38
2017
Q1
$1.56M Buy
25,772
+877
+4% +$53.2K 0.46% 40
2016
Q4
$1.4M Sell
24,895
-713
-3% -$41.7K 0.4% 42
2016
Q3
$1.52M Buy
+25,608
New +$1.5M 0.97% 28
2016
Q1
Sell
-7,336
Closed -$370K 69
2015
Q4
$370K Hold
7,336
0.44% 52
2015
Q3
$346K Buy
+7,336
New +$390K 0.31% 65
2015
Q2
Sell
-8,007
Closed -$439K 96
2015
Q1
$439K Buy
+8,007
New +$453K 0.44% 57
2014
Q4
Sell
-16,031
Closed -$909K 91
2014
Q3
$909K Buy
+16,031
New +$900K 0.96% 22
2014
Q2
Sell
-18,190
Closed -$986K 99
2014
Q1
$986K Buy
18,190
+2,591
+17% +$134K 0.67% 31
2013
Q4
$745K Buy
+15,599
New +$713K 0.65% 29

Other funds holding MRK

Plancorp LLC's MRK Position: Q2 2026 in Review

Plancorp LLC reduced its Merck (MRK) stake by 9% in Q2 2026, selling an estimated $141K and leaving 12,133 shares worth $1.5M. The position accounts for 0.04% of the portfolio, ranked #158.

Plancorp LLC first reported a position in MRK in Q4 2013 and has held it in 46 quarters since. The position peaked at $2.76M in Q4 2024. 1,153 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Plancorp LLC held 12,133 shares of Merck worth $1.5M as of Q2 2026.
  • Plancorp LLC sold 1,202 Merck shares in Q2 2026, an estimated $141K.
  • Merck made up 0.04% of Plancorp LLC's portfolio in Q2 2026, its #158 holding.
  • Plancorp LLC first reported a position in Merck in Q4 2013 and has held it in 46 quarters since.
  • Plancorp LLC's Merck position peaked at $2.76M in Q4 2024.
  • 1,153 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Plancorp LLC's 13F filing for Q2 2026, filed 14 Jul 2026.